Fillipo Peter Caldini
CEO & DirectorMr. Filippo Caldini, also known as Peter, served as Interim Chief Executive Officer of Establishment Labs Holdings Inc. since March 1, 2025 until May 7, 2025 and serves as its CEO since May 7, 2025 and also serves as its Director since May 24, 2025 and was its President since August 20, 2024 until March 01, 2025. Mr. Caldini joined the Establishment Labs Holdings Inc. in August 2024. He serves as Chief Executive Officer of Establishment Labs S.A. Mr. Caldini had been the Chief Executive Officer at Acreage Holdings, Inc. since joining on December 21, 2020 until June 30, 2023 and served as its Director since May 27, 2021 until 2023. He served as an Independent Director of Bespoke Capital Acquisition Corp. He served as Chief Executive Officer of Bespoke Capital Acquisition Corp until December 2020. He served as a Senior Advisor at Tuatara Capital, L. P. since joining in 2019. Mr. Caldini developed extensive commercial management expertise at Pfizer Inc., Bayer AG and Wyeth, Limited Liability Company. Mr. Caldini was the Regional President North America for Pfizer Consumer Healthcare from 2017 to 2019. As President of Pfizer Consumer Healthcare North America Mr. Caldini was responsible for managing the 2nd largest OTC consumer healthcare company in the region. He drove market share growth for leading brands Advil, Emergen-C, Nexium, Chapstick and Prep-H and improved the profitability of the business unit. Prior to that, he was the Regional President EMEA of Pfizer Consumer Healthcare from 2016 to 2017 and led the Northern European cluster from 2015 to 2016. He directed the successful brand launches of Nexium across Europe and the Viagra switch in the UK. He also led the successful acquisition of B-Total and the integration of Ferrosan in the Nordics and Russia. Mr. Caldini was at Bayer from 2009 to 2014, with roles including the Head of sub-region Emerging Markets EMEA, the General Manager of Bayer Consumer Care China and the Head of the Nutritionals Strategic Business unit, the global leader in nutritional supplements with brands One-A-Day, Berocca and Supradyn. From 2002 to 2009 Mr. Caldini was at Wyeth Limited Liability Company, where he was responsible for affiliates across LATAM and AsiaPac and also managed the Centrum brand globally. Early in his career Mr. Caldini held various leadership roles in brand management at Unilever in the US and Europe. Mr. Caldini holds Board roles with healthcare companies Kramer Labs, Solvotrin and PreMark Pharma. He has extensive global commercial experience having led business operations across North America, EMEA, LATAM and AsiaPac. He holds a Master's degree in International Economics and Management from SDA, Bocconi School of Management (Bocconi University in Milan, Italy) and an MBA from Northeastern University. He received his Bachelor of Arts in Political Science from Boston University. Mr. Caldini has B.A. in Political Science from Boston University.
Positions
- Company NameEstablishment Labs Holdings Inc.Stock CodeESTAPositionCEO & DirectorColleagues
- NSNicholas S. LewinChairman of the Board
- SRS. Ross MansbachGeneral Counsel & Chief Compliance Officer
- CECassandra E. HarrisSenior VP & CFO
- RDRoberto de MezervilleChief Technology Officer
- MWMalavika WilliamVP, Global Head of Marketing & Communications
- EJEdward J. SchutterIndependent Director
- AEAnn Esther CustinIndependent Non-Executive Director
- LGLeslie GillinIndependent Director
